Researchers successfully developed and validated task-specific metrics (TSM) for laparoscopic Nissen fundoplication, a critical phase in laparoscopic hiatal hernia repair (LHHR). Utilizing structured interviews with expert foregut surgeons and a simulation involving participants with varying surgical expertise, the study demonstrated high interrater reliability and significant validity evidence for both global and TSM assessments. These LHHR-specific […]

Intraoperative esophageal washout with povidone-iodine solution significantly reduces the presence of free intraluminal tumor cells during esophageal and cardiac carcinoma resection. Neoadjuvant treatment decreases the likelihood of malignant cells in the esophagus. Repetitive washout decreases detectable malignant cells, with a significant reduction after 10 maneuvers. This novel, feasible procedure can help eliminate tumor cells and […]

Indocyanine Green (ICG)-guided lymph node (LN) dissection during laparoscopic radical gastrectomy significantly improves the quality of lymphadenectomy in locally advanced gastric cancer (LAGC) patients post-neoadjuvant chemotherapy (NAC). A randomized controlled trial with 236 patients demonstrates that ICG increases LN retrieval and decreases non-compliance rates, particularly in cases without baseline measurable LNs and in those with […]

Transthoracic single-port-assisted laparoscopic gastrectomy (TSLG) demonstrates technical safety and feasibility in comparison to laparoscopic transhiatal approach (LTH) for Siewert type II adenocarcinoma of the esophagogastric junction. In a retrospective study, TSLG showed advantages, including increased harvested lymph nodes, reduced lower mediastinal lymph nodes, and longer proximal margins. The R0 gastrectomy rate was higher in the […]

Recurrence-free survival is a valid surrogate endpoint for overall survival in surgically resectable advanced oesophageal squamous cell carcinoma (oscc) patients receiving neoadjuvant chemotherapy. A strong correlation (kendall’s τ 0.797) was found between the two endpoints, particularly in patients with a more favorable response to neoadjuvant treatment. This suggests that recurrence-free survival can be used as […]

Patients with 1 metastatic lymph node had a median overall survival of 49.8 months, while those with 2 metastatic lymph nodes had an overall survival of 33.3 months. Survival was not significantly different between patients with 1 metastatic lymph node in 1 lymph node metastasis station and those with 2 metastatic lymph nodes in the […]

Proximal gastrectomy (PG) and total gastrectomy (TG) for upper-third advanced gastric cancer (AGC) and Siewert type II esophagogastric junction (EGJ) cancers yield similar overall survival rates (61.7% vs. 68.3%) and recurrence-free survival rates (86.7% vs. 83.3%). PG group had eight recurrences, but operation method was not identified as a prognostic factor of tumor recurrence in […]

Examining minimally invasive gastrectomy post-preoperative chemotherapy for advanced gastric cancer, this study included 150 patients, assessing safety and feasibility. The overall morbidity rate was 12%, with a higher incidence in total/proximal gastrectomy plus splenectomy cases. Robotic gastrectomy, especially in cases involving splenectomy, demonstrated significantly lower postoperative complications compared to the laparoscopic approach. The findings support […]